0.16 USD
▼-0.01-5.10%
盘后 0.16 0.00%
2026-11-20
市值
$14.70M
市盈率
—
EPS
-0.46
股息率
—
52 周区间
0.15 – 3.62
成交量
1.05M
Beta
1.81
目标价
3.79
52W 低 0.1552W 高 3.62
价格走势
公司简介
Context Therapeutics Inc., a clinical-stage biopharmaceutical company, develops products for the treatment of solid tumors. The company’s product candidate includes CTIM-76, a Claudin 6 (CLDN6) x CD3 bispecific antibody that is intended to redirect T-cell-mediated lysis toward malignant cells expressing CLDN6. It has a collaboration and licensing agreement with Integral Molecular, Inc. for the development of a CLDN6 bispecific monoclonal antibody for cancer therapy. The company was incorporated in 2015 and is headquartered in Philadelphia, Penn...